CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report) fell 2.9% on Thursday after an insider sold shares in the company. The company traded as low as $42.78 and last traded at $42.22. 282,558 shares ...

We recently published a list of Top 10 Insider Purchases Last Month. In this article, we are going to take a look at where ...

We recently published a list of Top 10 Insider Purchases Last Month. In this article, we are going to take a look at where ...

Hedge funds usually like to take advantage of stock-market unrest. Lately, they have helped spread it instead.

In this context, we’re here with a list of the 10 most profitable value stocks to buy now.

Investors with a lot of money to spend have taken a bullish stance on Goldman Sachs Group GS. And retail traders should know.

Stoltzfus said he continued to favor stocks over bonds, with an emphasis on the U.S. Although he added that investors should remain diversified, maintaining exposure to foreign markets like Europe and ...

Jane Fraser at Citi received the largest pay rise among Wall Street CEOs in 2024, but it is not all good news.

Top US banks registered strong comebacks in 2024, exceeding expectations, and they are virtually unanimous that this ...

Toronto's main stock index rallied on Friday as technology and financial shares led broad-based gains and Mark Carney was ...

For 2025, Goldman sees a 180,000-ton global copper deficit as growing demand for electrification, economic stimulus measures ...

Goldman Sachs CEO David Solomon also weighed in, saying that while businesses typically prefer lower tariffs, there’s an understanding of what Trump is trying to achieve. However, he emphasized that ...